Information Provided By: 
Fly News Breaks for August 29, 2019
TCON
Aug 29, 2019 | 07:05 EDT
H.C. Wainwright analyst Edward White started Tracon Pharmaceuticals with a Buy rating and $2 price target. While the company has had two disappointing study results since December 2018, its current product pipeline has value, White tells investors in a research note. He believes the stock should be trading above its current cash level and sees a good buying opportunity "for investors with a speculative strategy."
News For TCON From the Last 2 Days
There are no results for your query TCON
